[HTML][HTML] Risk factors for adverse outcome in infancy in meconium ileus cystic fibrosis infants: a multicentre Italian study

R Padoan, N Cirilli, D Falchetti, BM Cesana… - Journal of Cystic …, 2019 - Elsevier
Background Meconium ileus (MI) is a risk factor for poor outcomes in cystic fibrosis (CF)
patients. The aim of this study was to identify the risk factors for poor 12-month clinical …

[HTML][HTML] A real world evaluation of the long-term efficacy of strategies to prevent chronic Pseudomonas aeruginosa pulmonary infection in children with cystic fibrosis

F Mostofian, J Alkadri, K Tang, N Thampi… - International Journal of …, 2019 - Elsevier
Background Children with cystic fibrosis (CF) are susceptible to chronic Pseudomonas
aeruginosa (PA) infection. Early eradication of PA has proven short-term efficacy. No studies …

Mitigating the harm caused by Pseudomonas aeruginosa in Cystic Fibrosis

SC Palser - eprints.nottingham.ac.uk
Cystic fibrosis (CF) affects up to 100,000 people worldwide. Defects in the Cystic Fibrosis
Transmembrane Regulator (CFTR) gene cause abnormally viscid secretions at epithelial …

Actualités en infectiologie dans la mucoviscidose

C Marguet, L Lémée, H Morisse-Pradier, L Couderc - Archives de Pédiatrie, 2016 - Elsevier
Résumé Cette revue fait le point sur les actualités d'infectiologie dans la mucoviscidose.
Pour les mycobactéries non tuberculeuses, des recommandations internationales ont été …